中国医疗美容
中國醫療美容
중국의료미용
China Medical Cosmetology
2015年
5期
80-83
,共4页
透明质酸修护生物膜%他克莫司%复方倍他米松注射液%面部激素依赖性皮炎
透明質痠脩護生物膜%他剋莫司%複方倍他米鬆註射液%麵部激素依賴性皮炎
투명질산수호생물막%타극막사%복방배타미송주사액%면부격소의뢰성피염
Hyaluronan-containing emulsion%Tacrolimus%Diprospan%Facial corticosteroid addictive dermatitis
目的:观察透明质酸修护生物膜联合他克莫司及复方倍他米松注射液治疗面部激素依赖性皮炎的临床疗效。方法60例患者随机分为两组,治疗组30例外用透明质酸修护生物膜8周,联合外用他克莫司4周,同时单次肌肉注射复方倍他米松注射液;对照组仅外用他克莫司4周,两组均口服左西替利嗪片5 mg/d。结果治疗组起效时间为(1.75±0.62)d,对照组起效时间为(6.20±1.65)d。疗程结束后4周治疗组总有效率93.33%,对照组总有效率67.86%。两组比较差异有统计学意义(P﹤0.05)。结论透明质酸修护生物膜联合他克莫司及复方倍他米松注射液治疗面部激素依赖性皮炎疗效满意,安全可靠,值得基层皮肤科医师选择应用。
目的:觀察透明質痠脩護生物膜聯閤他剋莫司及複方倍他米鬆註射液治療麵部激素依賴性皮炎的臨床療效。方法60例患者隨機分為兩組,治療組30例外用透明質痠脩護生物膜8週,聯閤外用他剋莫司4週,同時單次肌肉註射複方倍他米鬆註射液;對照組僅外用他剋莫司4週,兩組均口服左西替利嗪片5 mg/d。結果治療組起效時間為(1.75±0.62)d,對照組起效時間為(6.20±1.65)d。療程結束後4週治療組總有效率93.33%,對照組總有效率67.86%。兩組比較差異有統計學意義(P﹤0.05)。結論透明質痠脩護生物膜聯閤他剋莫司及複方倍他米鬆註射液治療麵部激素依賴性皮炎療效滿意,安全可靠,值得基層皮膚科醫師選擇應用。
목적:관찰투명질산수호생물막연합타극막사급복방배타미송주사액치료면부격소의뢰성피염적림상료효。방법60례환자수궤분위량조,치료조30예외용투명질산수호생물막8주,연합외용타극막사4주,동시단차기육주사복방배타미송주사액;대조조부외용타극막사4주,량조균구복좌서체리진편5 mg/d。결과치료조기효시간위(1.75±0.62)d,대조조기효시간위(6.20±1.65)d。료정결속후4주치료조총유효솔93.33%,대조조총유효솔67.86%。량조비교차이유통계학의의(P﹤0.05)。결론투명질산수호생물막연합타극막사급복방배타미송주사액치료면부격소의뢰성피염료효만의,안전가고,치득기층피부과의사선택응용。
ObjectiveTo observe the outcome of hyaluronan-containing emulsion , tacrolimus and diprospan used together to treat facial corticosteroid addictive dermatitis. Methods 60 patients were randomly divided into two groups. Treatment group (30 cases) received hyaluronan-containing emulsion for 8 weeks and tacrolimus for 4 weeks with diprospan injected at the same time. Control group was only treated with tacrolimus for 4 weeks. Both groups took Levocetirizine Dihydrochloride Tablets 5mg/d.Results Onset time is (1.75±0.62) d in treatment group while it is (6.20±1.65)d in the other group. After 4 weeks’ treatment, the effectiveness of treatment group is 93.33% which is better than 67.86% in control group. Thedifferences were statistical significant (p<0.05). Conclusion Hyaluronan-containing emulsion combined with tacrolimus and diprospan are safe and effective for treating facial corticosteroid addictive dermatitis.